share_log

The Latest Analyst Ratings For Immunocore Hldgs

The Latest Analyst Ratings For Immunocore Hldgs

Immunocore Hldgs的最新分析師評級
Benzinga ·  08/28 08:00  · 評級/大行評級
In the last three months, 7 analysts have published ratings on Immunocore Hldgs (NASDAQ:IMCR), offering a diverse range of perspectives from bullish to bearish.
在最近的三個月裏,有7名分析師對Immunocore Hldgs(納斯達克代碼:IMCR)發表了評級意見,涵蓋了從看好到看淡的不同觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估,下表展示了過去30天內不斷變化的情緒,並將其與之前的幾個月進行了比較。
Analysts have recently evaluated Immunocore Hldgs and provided 12-month price targets. The average target is $83.29, accompanied by a high estimate of $100.00 and a low estimate of $66.00. Observing a downward trend, the current average is 4.58% lower than the prior average price target of $87.29.
淨利率:Immunocore Hldgs的淨利率令人印象深刻,超過行業平均水平。淨利率達到-15.41%,公司展示了強大的盈利能力和有效的成本管理。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析:詳細分析
An in-depth analysis of...
債務管理:...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論